InVivo’s team has been successfully producing the highest quality biologicals for over ten years. Our long-standing expertise in planning, manufacturing, quality testing, and documentation guarantees the highest level of customer service and satisfaction. Our full range of expression, fermentation, and cell-culture experience is at your disposal. Our employees are the core of our businesss. All InVivo employees receive regular quality assurance training and are personally committed to providing the highest level of service to our customers. InVivo currently employs 65 specialists. This workforce includes university graduates, biologists, chemists, engineers as well as degreed laboratory technicians.
Dr. Nils Morgenthaler, MBA – Managing Director
Dr. Nils Morgenthaler studied medicine at the University of Ulm and wrote his academic thesis in endocrinology. He completed his training at the university hospitals of Ulm and Leipzig, and at King’s College Hospital in London, specializing in internal medicine.
He left clinical medicine in 1997 to work for BRAHMS GmbH and played a key role in bringing novel in vitro diagnostic assays from bench to bedside, including TSH-receptor autoantibodies, Procalcitonin and Copeptin. After getting an executive MBA from the University of Potsdam, he became General Manager for GILUPI GmbH, and subsequently, Vice President for Clinical Business Development at Bruker Daltonics in Bremen. He joined InVivo Biotech Services as General Manager in 2017.
Dr. Morgenthaler has more than 20 years of management experience in the diagnostic industry, and a long track record of research collaborations, with over 200 scientific publications covering the fields of endocrinology/diabetes, infectious diseases/sepsis, cardiology and oncology.
Caterina Farnleitner – Head of Antibody and Protein Production
Caterina holds a Master´s degree in Chemistry with a specialization in Biochemistry and Protein production. Caterina has proudly represented InVivo’s Marketing and Business Development department for more than 10 years. She managed acquisitions, contributed to market outreach and optimized internal functions. 2019 onwards, she absorbs process control responsibilities in Antibody and Protein production while continuing as the chief consult for expanding InVivo’s business internationally.
Dr. Tim Welsink – Head of R&D Services
Tim’s academic background is the field of biochemistry. He studied at Freie Universität Berlin and Michigan State University and obtained a diploma degree in biochemistry. During his doctoral research in developing novel autoimmune assays at Charité Universitätsmedizin Berlin, he experienced the value of industrial contribution in academia. He joined InVivo in 2014 as head of the Molecular Biology department focusing on expression and purification of recombinant proteins, including recombinant antibodies.
Jennifer Suhr – Kits & Consumables
Jennifer Suhr completed her studies in 2004 as a biologist at the Humboldt University in Berlin with a focus on microbiology and molecular biology. After graduation, she worked in areas of cell culture, molecular biology and assay development. At Immunochemical Intelligence GmbH (ICI), she headed the “Production” department for seven years and then the “Quality Control” department with a focus on immunoassays. After the merger of ICI with InVivo BioTech Services GmbH in 2018, she took over the management of the “Operations” division in Berlin. Since May 2019, she heads the department of “Kits & Consumables”.